RxDoctor Payments Data

Bedoor Alabbas

Gastroenterology · Washington, DCNPI 1952751182

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 228 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 39.6% of the total. 2025 is the largest year on record at $1,703, more than ten times the $114 reported in 2019.

$4,262in general payments, 2019–2025

Across 228 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$519
  • Gilead$312
  • Takeda Pharmaceuticals U.S.A., Inc.$217
  • Madrigal Pharmaceuticals$162
  • Bristol Myers Squibb$145
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$4,262100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,262 in reported general payments places this provider in the 65th percentile of 77 gastroenterology providers in District of Columbia.

See all gastroenterology providers in District of Columbia

Medicare billing

Part B allowed, 2024
$79,480
Medicare patients
273
Services billed
570

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates12$834
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl58$753
Pantoprazole Sodium79$674
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl25$366
Famotidine26$327
Omeprazole16$195

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →